Presentation is loading. Please wait.

Presentation is loading. Please wait.

A Symposium on a new development of Proton Radiotherapy Nijmegen, September 17th, 2010 We want to contribute to optimal treatments for patients close to.

Published byDrake Amis Modified over 9 years ago

Similar presentations

Presentation on theme: "A Symposium on a new development of Proton Radiotherapy Nijmegen, September 17th, 2010 We want to contribute to optimal treatments for patients close to."— Presentation transcript:

1 A Symposium on a new development of Proton Radiotherapy Nijmegen, September 17th, 2010 We want to contribute to optimal treatments for patients close to their livings “Stand-alone Proton Units” : a modern technique, innovative and cost effective Jos J. Immerzeel, Radiation Oncologist, RISO

2 2 Introduction This presentation: Developments in the Netherlands CPAC and the initiative in Deventer Promises and Perils of the new development Aim of this conference Jos J. Immerzeel

3 3 Developments in the Netherlands 2008: three initiatives in NL: Groningen, UMCG: protoncenter nearby nuclear- physics-accelerator-research center Maastricht: Euregional cooperation (with GER/BE) Amsterdam (NKI)- Rotterdam (Erasmus Univ.)- Leiden (Univ.)- Delft (Techn. Univ): Holland PTC 2009: National Health Counsil: positive (conditional) standpoint 2009: CvZ (College for Health Insurances): report on development of protontherapy; indications 2010: Gouvernmental Decision expected Q4 Jos J. Immerzeel

4 4 Developments in the Netherlands Potential indications: 7000 # units needed: 10-15 “Classic” Protoncenter: 3-4 units Is another initiative for proton therapy in East NL necessary? Jos J. Immerzeel “Standard” indications in NL: 250

5 5 CPAC and the initiative in Deventer 2007: Tomotherapy: DWA development --> CPAC CPAC searches >15 investors/shareholders: RISO? Three investment tranches, three milestones March 2008: Board of RISO informed: positive about the opportunity Juli 2008: Board decision: participate, but no public (RISO) risk-investments possible. Need to search for private investors. Jos J. Immerzeel  2006: new RISO building, also 2 Tomotherapy (IMRT) units; up to now unique in the NL…

6 6 CPAC and the initiative in Deventer (2) Establishment of DEVPRON BV Second and third tranche: after end of risk period private investment + loan RISO (public ) Milestone 2009: acceleration of protons in a subscale DWA Jos J. Immerzeel First tranche: own investment with funding party. Risk investment (private)

7 7 CPAC and the initiative in Deventer (3) Participation in DEVPRON BV by the director should be less than 5% Investments by RISO in DWA is only possible when risk towards a succesful development is deminished. After this: the loan of RISO to Devpron BV can be considered as downpayment/investment Once decided to buy a unit, Devpron BV would be taken over by RISO. Jos J. Immerzeel Standpoints of Board of RISO:

8 8 Investors : first rights to achieve treatment units Participation in CPAC Scientific Advisory Board Installation of Stearing group (Stakeholders) Prof. Jurgen Debus (Heidelberg Ion-beam Therapy centre): Advisor for RISO RISO: search for partners (University!) CPAC and the initiative in Deventer (4) Jos J. Immerzeel 2010: promising developments of DWA

9 9 Regional cooperation: Technical University Twente and radiotherapy centers National: Investigation for cooperation with other initiatives CPAC and the initiative in Deventer (5) Jos J. Immerzeel July 2010: Partnership with University of Nijmegen/ St. Radboud

10 10 Promises and Perils of the new development Lower costs regarding infrastructure Lower costs for personell No admixture with neutrons BUT: Dose distribution of Protons: to good! Imaging and dosimetry: extremely important DWA is still a concept….. Jos J. Immerzeel  Installation in existing radiation oncology centers (single vault units)

11 11 Aim of this conference To inform the audience about the DWA compact Proton Accelerator and the initiative of Deventer /Nijmegen: more than a concept? To convince stakeholders, decision-makers and collegues that this new development really is a chance To initiate cooperation with the other initiatives (UMCG, Holland PTC, Maastricht) Jos J. Immerzeel

12 12 Cooperation in the Netherlands: Jos J. Immerzeel

13 13 Programme, Speakers Jos J. Immerzeel IntroductionJ. Immerzeel Clinical experience of particle therapy in Heidelberg M. Münter Technical aspects of protontherapyJ. Schippers DWA developmentsR. Mackie Coffee, Tea Proton facilitiesJ.W. Leer The UMC St.Radboud-RISO collaborationA. Minken PaneldiscussionJ.W. Leer Farewell reception

Download ppt "A Symposium on a new development of Proton Radiotherapy Nijmegen, September 17th, 2010 We want to contribute to optimal treatments for patients close to."

Similar presentations

Gert-Jan Euverink, deputy-director research. First initiative in The Netherlands bridging the gap between: Bio- and separation technology Drinking water.

Gert-Jan Euverink, deputy-director research. First initiative in The Netherlands bridging the gap between: Bio- and separation technology Drinking water.
Information and Communication Technologies (ICT) in the Seventh Framework Programme Coordination actions ICT Calls Jan- March 2012.

Information and Communication Technologies (ICT) in the Seventh Framework Programme Coordination actions ICT Calls Jan- March 2012.
INFSO/F3 1 The TEN-Telecom Programme Jose Soler INFSO/F3, EC TEN-TELECOM Information Day.

INFSO/F3 1 The TEN-Telecom Programme Jose Soler INFSO/F3, EC TEN-TELECOM Information Day.
Electric Vehicles Industrial Cluster - NPO IKEM Corp. (Business entity of EVIC) Changing the Government Agenda of EU's poorest countries using the power.

Electric Vehicles Industrial Cluster - NPO IKEM Corp. (Business entity of EVIC) Changing the Government Agenda of EU's poorest countries using the power.
Collaboration UMC St Radboud - RISO

Collaboration UMC St Radboud - RISO
Why and how we became a mutual Graham Barnes MyCSP Ltd.

Why and how we became a mutual Graham Barnes MyCSP Ltd.
Shareholders Meeting August 22, 2013 CONFIDENTIAL1.

Shareholders Meeting August 22, 2013 CONFIDENTIAL1.
Introduction to EuCARD2 & WP4: Applications of Accelerators AccApplic  EuCARD2  WP4: Applications of Accelerators  The applications  Current workshops.

Introduction to EuCARD2 & WP4: Applications of Accelerators AccApplic  EuCARD2  WP4: Applications of Accelerators  The applications  Current workshops.
1 BSR InnoReg Panevezys review of WP4 18 January 2011.

1 BSR InnoReg Panevezys review of WP4 18 January 2011.
Expression of Interest UNICA Science Parks and Incubator Network.

Expression of Interest UNICA Science Parks and Incubator Network.
1 A frank dialogue on the future of HIV treatment All the way from the factory to the patient Sunday 20 th July 2014, 13:30 – 15:30 Presented at the 20.

1 A frank dialogue on the future of HIV treatment All the way from the factory to the patient Sunday 20 th July 2014, 13:30 – 15:30 Presented at the 20.
Stereotactic Body Radiation Therapy (SBRT): The optimal indication for operable tumors in inoperable patients D.Katsochi 1, S.Kosmidis 1, A.Fotopoulou.

Stereotactic Body Radiation Therapy (SBRT): The optimal indication for operable tumors in inoperable patients D.Katsochi 1, S.Kosmidis 1, A.Fotopoulou.
The Health Roundtable 1-1b_HRT1215-Session_HEGI_JOHNSON_WESTMEAD_NSW Volumetric Modulated Arc Therapy for Stereotactic Body Radiotherapy in Early Lung.

The Health Roundtable 1-1b_HRT1215-Session_HEGI_JOHNSON_WESTMEAD_NSW Volumetric Modulated Arc Therapy for Stereotactic Body Radiotherapy in Early Lung.
ARDENT MEETING Andrej Sipaj June 13 th, 2013. ABOUT ME  Born and raised in Slovakia  Studied: BEng in Mechanical Engineering at UOIT, Canada MASc in.

ARDENT MEETING Andrej Sipaj June 13 th, ABOUT ME  Born and raised in Slovakia  Studied: BEng in Mechanical Engineering at UOIT, Canada MASc in.
DUTCH RESEARCH let us inspire your career Presentation for the PhDTalent event, September 21st 2012, Paris Virginie Jazede, ANSES, Maison-Alfort Anièce.

DUTCH RESEARCH let us inspire your career Presentation for the PhDTalent event, September 21st 2012, Paris Virginie Jazede, ANSES, Maison-Alfort Anièce.
Saxion University of Applied Sciences The Netherlands

Saxion University of Applied Sciences The Netherlands
1 VSNU Association of Universities in the Netherlands Dutch Universities: innovative education and Internationalization Prof. Dr. M. Paul, Prseident, Maastricht.

1 VSNU Association of Universities in the Netherlands Dutch Universities: innovative education and Internationalization Prof. Dr. M. Paul, Prseident, Maastricht.
LOGO Foundation for Assistance to Small Innovative Enterprises (FASIE) 2014 State Activities to Support Innovations in Russia.

LOGO Foundation for Assistance to Small Innovative Enterprises (FASIE) 2014 State Activities to Support Innovations in Russia.
The Value of Partnerships in Fighting HIV/AIDS in Romania: Bringing Children New Hope Jeffrey L. Sturchio Vice President, External Affairs Europe, Middle.

The Value of Partnerships in Fighting HIV/AIDS in Romania: Bringing Children New Hope Jeffrey L. Sturchio Vice President, External Affairs Europe, Middle.
Report from WP4: Applications of Accelerators AccApplic  Accelerator Applications  Aims of WP4  Workshops so far  Future workshops  Status  Plans.

Report from WP4: Applications of Accelerators AccApplic  Accelerator Applications  Aims of WP4  Workshops so far  Future workshops  Status  Plans.

Similar presentations

Ads by Google